Artificial Pancreas Technology Battles Hypoglycemia
By HospiMedica International staff writers Posted on 02 Feb 2015 |
Innovative predictive low glucose management technology helps diabetics achieve better glucose control through advanced protection from hypoglycemia.
The MiniMed 640G System incorporates exclusive SmartGuard technology, which both automatically suspends insulin delivery when the enhanced Enlite glucose sensor predicts levels are approaching the lower limit, and resumes insulin delivery once glucose levels recover. Multiple low-limit settings can be tailored to meet individual needs throughout the day. Other features include a simple menu, a full-color management screen with automatic light-adjustment, customizable alerts and alarms, and waterproofing in up to 3.65 meters of water for 24 hours at a time.
In addition, the system exclusively uses the Bayer (Leverkusen, Germany) Contour Next Link 2.4 blood glucose meter to provide highly accurate blood glucose testing and automatically transmit blood glucose results into the Bolus Wizard calculator. This also helps ensure that patients do not have a manual entry error, as well as calibrate the Enlite sensor. It also allows patients to discreetly give a bolus of insulin remotely from the meter. The MiniMed 640G System and SmartGuard technology are products of Medtronic (Minneapolis, MN, USA).
“We developed this system based on substantial amounts of research and feedback from the global diabetes community, who are looking for simpler, more convenient diabetes technology that helps them achieve better glucose control and enjoy greater freedom,” said Alejandro Galindo, vice president and general manager of the intensive insulin management business at Medtronic. “With the MiniMed 640G, we're thrilled to deliver a new system that meets these needs and marks the third significant milestone to creating and commercializing the world's first artificial pancreas.”
“By suspending insulin delivery before the sensor glucose reaches a low limit, the MiniMed 640G System can help prevent severe hypoglycemia,” said Prof. Tim Jones, MD, head of the diabetes department at Princess Margaret Hospital (Perth, Australia). “In addition, with this new feature, hyperglycemic rebound may be avoided by resuming insulin delivery once those glucose levels recover, making this a very valuable tool for achieving better glucose control.”
Related Links:
Medtronic
Bayer
The MiniMed 640G System incorporates exclusive SmartGuard technology, which both automatically suspends insulin delivery when the enhanced Enlite glucose sensor predicts levels are approaching the lower limit, and resumes insulin delivery once glucose levels recover. Multiple low-limit settings can be tailored to meet individual needs throughout the day. Other features include a simple menu, a full-color management screen with automatic light-adjustment, customizable alerts and alarms, and waterproofing in up to 3.65 meters of water for 24 hours at a time.
In addition, the system exclusively uses the Bayer (Leverkusen, Germany) Contour Next Link 2.4 blood glucose meter to provide highly accurate blood glucose testing and automatically transmit blood glucose results into the Bolus Wizard calculator. This also helps ensure that patients do not have a manual entry error, as well as calibrate the Enlite sensor. It also allows patients to discreetly give a bolus of insulin remotely from the meter. The MiniMed 640G System and SmartGuard technology are products of Medtronic (Minneapolis, MN, USA).
“We developed this system based on substantial amounts of research and feedback from the global diabetes community, who are looking for simpler, more convenient diabetes technology that helps them achieve better glucose control and enjoy greater freedom,” said Alejandro Galindo, vice president and general manager of the intensive insulin management business at Medtronic. “With the MiniMed 640G, we're thrilled to deliver a new system that meets these needs and marks the third significant milestone to creating and commercializing the world's first artificial pancreas.”
“By suspending insulin delivery before the sensor glucose reaches a low limit, the MiniMed 640G System can help prevent severe hypoglycemia,” said Prof. Tim Jones, MD, head of the diabetes department at Princess Margaret Hospital (Perth, Australia). “In addition, with this new feature, hyperglycemic rebound may be avoided by resuming insulin delivery once those glucose levels recover, making this a very valuable tool for achieving better glucose control.”
Related Links:
Medtronic
Bayer
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure